04.04.2017 • TopicsDr. Gerd BergmannNordmannNRC

‘Digitalization Transforms Communication’

Hans-Joachim Müller, CEO, Azelis
Hans-Joachim Müller, CEO, Azelis

“At Azelis we place great importance on collecting and analyzing data to gain insight into marketing trends and buying behavior. Data becomes more than a tool — it’s the first step of our sales process. By utilizing a superior ERP tool, an integrated analytics platform that allows for data mining and advanced analytics, we collect and analyze data in order to provide necessary services to our customers.

In an environment where any information is just a click away, we are aware of the way digitalization transforms communication and the way we handle information.

Digitalization as the main force behind the standardization of back-office processes has far-reaching consequences. With increased process efficiency, we can focus more on formulation development and our customers. Further down the road, this opens up a new world of possibilities for specialty chemicals distributors — a world in which highly personalized services and customized products are not only here, but here to stay.”

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
19.03.2025 • TopicsStrategy

Substances of Concern

The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.

Photo
14.05.2025 • TopicsPharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.